Failing to meet analysts’ top-line estimates, Amyris reported a 30% year-over-year decline in its ingredients business, to the chagrin of investors, and it seems as if the company will continue to face challenges in the fourth quarter.
Similarly, What kind of company is Amrs?
Amyris, Inc. is a synthetic biotechnology company.
Will Amyris stock go back up? The Amyris stock price gained 3.98% on the last trading day (Wednesday, 13th Apr 2022), rising from $4.27 to $4.44.
…
Predicted Opening Price for Amyris of Thursday, April 14, 2022.
| Fair opening price April 14, 2022 | Current price |
|---|---|
| $4.36 | $4.44 (Overvalued) |
Thereof, Is Ginkgo Bioworks publicly traded?
Ginkgo Bioworks — a Boston-based company that wants to make biology as easy to program as a computer — began trading on Friday after going public via a SPAC. Why it matters: Ginkgo’s multibillion-dollar offering is a milestone in the maturation of synthetic biology from a science to a true industry.
Is Zymergen publicly traded?
Zymergen shares (ZY) are listed on the NASDAQ and all prices are listed in US Dollars.
What does Amrs company do?
Using sugarcane fermentation, we convert basic plant sugars into rare bioidentical molecules, essential ingredients and clean, effective everyday products. We are passionately pioneering the future of clean chemistry where people and planet can prosper.
When did Amrs go public?
The company went public on NASDAQ on September 28, 2010 (AMRS).
Who owns Amyris Inc?
General Public Ownership
A substantial ownership of 40.97% in AMRS is held by the general public. This size of ownership gives retail investors collective power in deciding on major policy decisions such as executive compensation, appointment of directors and acquisitions of businesses.
Does Amyris pay dividends?
AMYRIS (NASDAQ: AMRS) does not pay a dividend.
How big is Amyris?
Amyris has said it expects 2021 revenue of around $400 million. Investors have taken notice. Its stock is up 10-fold over the past year, at a recent $22, giving the company a market cap of $5.9 billion.
What does Amyris Inc do?
Amyris, Inc. produces and distributes chemical products. The Company serves the specialty and performance chemicals, flavors and fragrances, cosmetics ingredients, pharmaceuticals, and nutraceuticals markets.
Does Bill Gates own ginkgo bioworks?
Bill Gates backs Ginkgo Bioworks‘ $350M raise to fuel the buzzy synthetic biology ‘revolution’ – Endpoints News.
Who invested in ginkgo?
Ginkgo’s proceeds come from a private placement of $775 million from investors — led by Baillie Gifford, Putnam Investments, and Morgan Stanley — and about $858 million from the Soaring Eagle trust account.
Who has invested in ginkgo?
The deal included a $775 million private placement led by Baillie Gifford, Putnam Investments and Morgan Stanley Investment Management’s Counterpoint Global arm. So-called PIPE financing is a mechanism for companies to raise capital from a select group of investors that make the final market debut possible.
Should I invest in Zymergen?
Valuation metrics show that Zymergen Inc. may be overvalued. Its Value Score of F indicates it would be a bad pick for value investors. The financial health and growth prospects of ZY, demonstrate its potential to underperform the market.
Is Zymergen a good stock to buy?
There are currently 3 sell ratings and 5 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should « hold » Zymergen stock.
Why is Zymergen stock down?
Zymergen ( ZY -9.82% ) stock sank on Tuesday, falling 12.6% as of 1 p.m. EDT as the stock’s lock-up period expired. Notably, Zymergen shares had gained some ground in the past week but with today’s drop, shares of the « biofacturing » start-up have cracked 20% in one month and 69% in the past three months.
Who is Biossance owned by?
On March 1, Amyris, which owns Biossance and children’s skin-care brand Pipette, announced it acquired clean luxury beauty brand Costa Brazil for an undisclosed sum and that founder Francisco Costa will become the chief creative officer of the parent company.
What does amyris produce?
Amyris, Inc. produces and distributes chemical products. The Company serves the specialty and performance chemicals, flavors and fragrances, cosmetics ingredients, pharmaceuticals, and nutraceuticals markets.
How many employees does Amyris have?
Compare AMRS With Other Stocks
| Amyris Annual Number of Employees | |
|---|---|
| 2020 | 595 |
| 2019 | 192 |
| 2018 | 503 |
| 2017 | 414 |
Join TheMoney.co community and don’t forget to share this post !
